Alterations of the p53, Rb and MDM2 genes in osteosarcoma

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 9, 1996, Pages 559-565

  Miller, Carl W ^b   Aslo, Abdulkarim ^b   Won, Alvina ^b   Tan, Michael ^b   Lampkin, Beatrice ^a   Koeffler, H Phillip ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

MDMZ; Osteosarcoma; p53; Rb; Sarcoma

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CELL ONCOGENE; CONTROLLED STUDY; GENE REARRANGEMENT; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; OSTEOSARCOMA; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029791852     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01213553     Document Type: Article

References (59)

1. Abramson DH, Ronner HJ, Ellsworth RM (1979) Second tumors in nonirradiated bilateral retinoblastoma, Am J Ophthalmol 87: 624-637
2. Andreassen A, Oyjord T, Hovig E, Holm R, Florenes VA, Nesland JM, Myklebost O,Hoie J, Bruland OS, Borresen AL, Fodstadt O (1993) p53 abnormalities in different subtypes of human sarcomas. Cancer Res 53:468-471
3. Araki N, Uchida A, Kimura T, Yoshikawa H, Aoki Y, Ueda T, Takai S, Miki T, Ono K (1991) Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors. Clin Orthop 270:271-277
4. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW (1988) Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294-3298
5. Brachman DG, Hallahan DE, Beckett MA, Yandell DW, Weichselbaum RR (1991) p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Caneer Res 51:6393-6396
6. Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP (1988) A variation in the structure of the protein-coding region of the human p53 gene. Gene 70:245-252
7. Carbone D, Chiba I, Mitsudomi T (1991) Polymorphism at codon 213 within the p53 gene. Oncogene 6:91-92
8. Cheng J, Haas M (1990) Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 10:5502-5509
9. Fakharzadeh S, Trusko RS, George DL (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. HMBO J 10:1565-1569
10. Feinberg AP, and Vogelstein B (1983) A technique for radiolabeling DNA restriction endonticlease fragments to high specific activity. Anal Biochem 132:6-13
11. Forus A, Florenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O (1993) Mapping of amplification units in the q13 14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ 4:1065-1070
12. Fuchs N, Winkler K (1993) Osteosarcoma. Curr Opin Oncol 5:667-671
13. Fung YK, Murphree AL, T'Ang A, Qian J, Hinrichs SH, Benedict WF (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236:1657-1661
14. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646
15. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Caneer Res 54:4855-4878
16. Harlow H, Williamson NM, Ralston R, Helfman DM, Adams TE (1985) Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol 5:1601-1610
17. Harlwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266:1821-1828
18. lavarone A, Matthay K, Steinkirchner TM, Israel MA (1992) Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma. Proc Natl Acad Sci USA 89:4207-4209
19. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT (1993) Coamplification of the CDK-4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53:5535-5541
20. Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG, Healey JH (1993) MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53:16-18
21. Laimins LA (1993) The biology of human papillomaviruses: from warts to cancer. Infect Agents Dis 2:74-86
22. Lane DP, Crawford LV (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263
23. Lee WH, Bookstein R, Lee EY (1988) Studies on the human retinoblastoma susceptibility gene. J Cell Biochem 38:213-227
24. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935
25. Lubbert M, Mirro J Jr, Miller CW, Kahn J, Isaac G, Kitchingman G, Mertelsmann R, Herrmann F, McCormick F, Koeffler HP (1990) N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood 75:1163-1169
26. Ludlow JW (1993) Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J 7:866-871
27. McCormick F, Harlow E (1980) Association of a murine 53.000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol 3:213-224
28. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238
29. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ (1987) Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 84:7716-7719
30. Merlo GR, Cropp CS, Callahan R, Takahashi T (1991) Detection of loss of heterozygosity in tumor DNA samples by PCR. Biotechniques 11:166 -170
31. Miller CW, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguchida J, Yamamuro T, Lampkin B, Koeffler HP (1990) Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50:7950-7954
32. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245
33. Moran E (1993) Interaction of adenoviral proteins with pRB and p53. FASEB J 7:880-885
34. Mulligan LM, Matlashewski GJ, Scrable HJ, Cavenee WK (1990) Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci USA 87:5863-5867
35. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hosteller R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705 -708
36. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p55-associated protein in human sarcomas. Nature 358:80-83
37. Oren M (1994) Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol 5:221-227
38. Ozaki T, Ikeda S, Kawai A, Inoue H, Oda T (1993) Alterations of retinoblastoma susceptible gene accompanied by c-nivc amplification in human bone and soft tissue tumors. Cell Mol Biol 39:235-242
39. Pedeutour F, Suijkerbuijk RF, Forus A, Van Gaal J, Van de Klundert W, Coindre JM, Nicolo G, Collin F, Van Haelst U, Huffermann K, Turc-Carel C (1994) Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 10:85-94
40. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP (1994) Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4. SAS. and MDM2. Cancer Res 54:4299 -4303
41. Reissmann PT, Simon MA, Lee WH, Slamon DJ (1989) Studies of the retinoblastoma gene in human sarcomas. Oncogene 4:839-843
42. Romano JW, Ehrhart JC, Duthu A, Kim CM, Appella E, May P (1989) Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line. Oncogene 4:1483 -1488
43. Scheffer H, Kruize YC, Osinga J, Kuiken G, Oosterhuis JW, Leeuw JA, Schraffordt Koops H, Buys CH (1991) Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma. Cancer Genet Cytogenet 53:45 -55
44. Scholz RB, Kabisch H, Weber B, Roser K, Delling G, Winkler K (1992) Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol 9:125-137
45. Shew JY, Ling N, Yang XM, Fodstad O, Lee WH (1989) Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas. Oncogene Res 4:205-214
46. Smith-Sorensen B, Gebhardt MC, Kloen P, McIntyre J, Aguilar F, Cerutti P, Borresen AL (1993) Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE). Hum Mutat 2:274-285
47. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B (1994) Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 57:1-9
48. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747-749
49. Stratton MR, Williams S, Fisher C, call A, Westbury G, Gusterson BA, Fletcher CD, Knight JC, Fung YK, Reeves BR, Cooper CS (1989) Structural alterations of the RB1 gene in human soft tissue tumours. Br J Cancer 60:202-205
50. Stratton MR, Moss S, Warren W, Patterson H, Clark J, Fisher C, Fletcher CD, Ball A, Thomas M, Gusterson BA, Cooper CS (1990) Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene 5:1297 -1301
51. Toguchida J, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T (1988) Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 48:3939-3943
52. Toguchida J, Ishizaki K, Nakamura Y, Sasaki MS, Ikenaga M, Kato M, Sugimoto M, Kotoura Y, Yamamuro T (1989) Assignment of common allele loss in osteosarcoma to the subregion 17p13 Cancer Res 49:6247-6251
53. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Wcichselbaum RR, Ishizaki K, Yandell DW (1992a) Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52:6194-6199
54. Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera Geichselbaum RR, Yandell DW, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, et al (1992b) Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 326:1301-1308
55. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T (1994) Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-3048
56. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
57. Xu HJ, Hu SX, Hashimoto T, Takahashi R, Benedict WF (1989) The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene 4:807-812
58. Yamaguchi T, Toguchida J, Yamamuro T, Kotoura Y, Takada N, Kawaguchi N, Kaneko Y, Nakamura Y, Sasaki MS, Ishizaki K (1992) Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 52:2419-2423
59. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937 -948